[Psychiatric approach in peripheral vascular diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology; D002302:Cardiac Output; D003863:Depression / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007046:Hysteria; D007490:Iproniazid / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply; D008209:Lymphedema / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000209:etiology; D011602:Psychophysiologic Disorders; D012154:Reticular Formation; D013315:Stress, Psychological / Q000150:complications / Q000209:etiology; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology*; D014655:Vascular Resistance
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D007490:Iproniazid
Abord pschiatrique des maladies vasculaires périphériques.